Diabetes - Continuous Subcutaneous Insulin Infusion
Recommendations and Evidence
Advances in technology and knowledge of diabetes management have offered enhanced options for individuals with diabetes to optimize their glycemic control (1). Coupled with self-management education, intensive diabetes management, including multiple daily injections (MDI) or continuous subcutaneous insulin infusion (CSII), is associated with a reduced risk of diabetes microvascular and macrovascular complications (1, 2, 3).
Insulin dosing strategies should be individualized based on the